DrugPatentWatch Database Preview
OXAYDO Drug Profile
Which patents cover Oxaydo, and what generic alternatives are available?
Oxaydo is a drug marketed by Egalet Us Inc and is included in one NDA. There are six patents protecting this drug.
The generic ingredient in OXAYDO is oxycodone hydrochloride. There are nineteen drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the oxycodone hydrochloride profile page.
Summary for OXAYDO
| US Patents: | 6 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 3 |
| Bulk Api Vendors: | 8 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for OXAYDO |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for OXAYDO |
| DailyMed Link: | OXAYDO at DailyMed |
Pharmacology for OXAYDO
| Drug Class | Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |
US Patents and Regulatory Information for OXAYDO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Egalet Us Inc | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-001 | Jun 17, 2011 | RX | No | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Egalet Us Inc | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-002 | Jun 17, 2011 | RX | No | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Egalet Us Inc | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-001 | Jun 17, 2011 | RX | No | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Egalet Us Inc | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-002 | Jun 17, 2011 | RX | No | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Egalet Us Inc | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-002 | Jun 17, 2011 | RX | No | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Egalet Us Inc | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-001 | Jun 17, 2011 | RX | No | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for OXAYDO
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Israel | 221018 | ➤ Sign Up |
| Israel | 175863 | ➤ Sign Up |
| Australia | 2010200979 | ➤ Sign Up |
| Canada | 2547334 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 2005053587 | ➤ Sign Up |
| Australia | 2013206525 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for OXAYDO
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 292 | Luxembourg | ➤ Sign Up | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
